This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
This study focused on children with Tuberous Sclerosis Complex (TSC), a genetic condition that can cause various health issues, including tumors in different organs and early-onset epilepsy.
This study looked at treatments for two serious conditions in children: new onset refractory status epilepticus (a type of severe seizure) and febrile infection-related epilepsy syndrome (a condition that can cause seizures after a fever).
This study looked at the cost-effectiveness of a medication called brivaracetam (BRV) for treating patients in Jordan who have focal-onset seizures that do not respond to other treatments.
A recent study looked at how doctors in Germany, Austria, and Switzerland treat a serious condition called status epilepticus (SE), which is a prolonged seizure that can be life-threatening.
Researchers studied how to improve surgical strategies for patients with drug-resistant temporal lobe epilepsy (TLE) using a method called stereo-electroencephalography (SEEG).
Researchers studied how effective a specific brain stimulation treatment is for children with difficult-to-treat epilepsy.
This study looked at how effective vagus nerve stimulation (VNS) is for treating drug-resistant epilepsy (DRE) in children.
Researchers studied the use of ketogenic therapy, a special diet that can help control seizures, in infants aged 18 months or younger.
This study looked at the MEFV gene and its possible connection to drug-resistant epilepsy (DRE) in children.